Literature DB >> 19998063

Visceral obesity and metabolic syndrome: two faces of the same medal?

Rosario Scaglione1, Tiziana Di Chiara, Tiziana Cariello, Giuseppe Licata.   

Abstract

In this review, we have analyzed the role of visceral obesity in the occurrence of metabolic syndrome (MetS). MetS is a common metabolic disorder that has been related recently to the increasing prevalence of obesity. The disorder is defined in various ways, but in the near future a new definition(s) should be applicable worldwide. The pathophysiology has been largely attributed, in the past years, to insulin resistance, although several epidemiological and pathophysiological data now indicate visceral obesity as a main factor in the occurrence of all the components of MetS. In view of this, relationships among visceral obesity, free fatty acids, dyslipidemia and insulin resistance have been reported. In addition, the effects of some adipocytokines and other proinflammatory factors produced by fat accumulation on the occurrence of MetS have been also emphasized. Accordingly, the "hypoadiponectinemia hypothesis" has been proposed as the most interesting to explain the pathophysiology of MetS. The epidemiologic, pathophysiologic and clinical data reported seem to indicate that MetS might be considered a fatal consequence of visceral obesity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19998063     DOI: 10.1007/s11739-009-0332-6

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


  47 in total

1.  Serum adiponectin is a predictor of coronary heart disease: a population-based 10-year follow-up study in elderly men.

Authors:  Jan Frystyk; Christian Berne; Lars Berglund; Karin Jensevik; Allan Flyvbjerg; Björn Zethelius
Journal:  J Clin Endocrinol Metab       Date:  2006-11-21       Impact factor: 5.958

2.  Involvement of the renin-angiotensin system in obesity: older and newer pathways.

Authors:  Ferruccio Galletti; Pasquale Strazzullo
Journal:  Nutr Metab Cardiovasc Dis       Date:  2007-08-14       Impact factor: 4.222

3.  Sexual differentiation; Factor determining forms of obesity.

Authors:  J VAGUE
Journal:  Presse Med       Date:  1947-05-24       Impact factor: 1.228

4.  Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease.

Authors:  Carmine Zoccali; Francesca Mallamaci; Giovanni Tripepi; Francesco A Benedetto; Sebastiano Cutrupi; Saverio Parlongo; Lorenzo S Malatino; Graziella Bonanno; Giuseppe Seminara; Francesco Rapisarda; Pasquale Fatuzzo; Michele Buemi; Giacomo Nicocia; Sachiyo Tanaka; Noriyuki Ouchi; Shinji Kihara; Tohru Funahashi; Yuji Matsuzawa
Journal:  J Am Soc Nephrol       Date:  2002-01       Impact factor: 10.121

Review 5.  Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation.

Authors:  K G M M Alberti; P Zimmet; J Shaw
Journal:  Diabet Med       Date:  2006-05       Impact factor: 4.359

6.  Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity.

Authors:  Y Arita; S Kihara; N Ouchi; M Takahashi; K Maeda; J Miyagawa; K Hotta; I Shimomura; T Nakamura; K Miyaoka; H Kuriyama; M Nishida; S Yamashita; K Okubo; K Matsubara; M Muraguchi; Y Ohmoto; T Funahashi; Y Matsuzawa
Journal:  Biochem Biophys Res Commun       Date:  1999-04-02       Impact factor: 3.575

Review 7.  Adiponectin and adiponectin receptors.

Authors:  Takashi Kadowaki; Toshimasa Yamauchi
Journal:  Endocr Rev       Date:  2005-05       Impact factor: 19.871

8.  Adiponectin and the development of type 2 diabetes: the atherosclerosis risk in communities study.

Authors:  Bruce B Duncan; Maria Inês Schmidt; James S Pankow; Heejung Bang; David Couper; Christie M Ballantyne; Ron C Hoogeveen; Gerardo Heiss
Journal:  Diabetes       Date:  2004-09       Impact factor: 9.461

9.  Relationship between circulating E-selectin, DD genotype of angiotensin-converting-enzyme, and cardiovascular damage in central obese subjects.

Authors:  Giuseppe Licata; Tiziana Di Chiara; Anna Licata; Giovanni Triolo; Christiano Argano; Antonio Pinto; Gaspare Parrinello; Salvatore Corrao; Giovanni Duro; Rosario Scaglione
Journal:  Metabolism       Date:  2003-08       Impact factor: 8.694

10.  Diagnostic criteria for metabolic syndrome: a comparative analysis in an unselected sample of adult male population.

Authors:  Pasquale Strazzullo; Antonio Barbato; Alfonso Siani; Francesco P Cappuccio; Marco Versiero; Pierluigi Schiattarella; Ornella Russo; Sonia Avallone; Elisabetta della Valle; Eduardo Farinaro
Journal:  Metabolism       Date:  2008-03       Impact factor: 8.694

View more
  14 in total

1.  Effects of serum uric acid levels on the arginase pathway in women with metabolic syndrome.

Authors:  S Uslu; E Ozcelik; N Kebapci; H E Temel; F Demirci; B Ergun; C Demirustu
Journal:  Ir J Med Sci       Date:  2015-08-02       Impact factor: 1.568

2.  Effect of soy on metabolic syndrome and cardiovascular risk factors: a randomized controlled trial.

Authors:  Massimiliano Ruscica; Chiara Pavanello; Sara Gandini; Monica Gomaraschi; Cecilia Vitali; Chiara Macchi; Beatrice Morlotti; Gilda Aiello; Raffaella Bosisio; Laura Calabresi; Anna Arnoldi; Cesare R Sirtori; Paolo Magni
Journal:  Eur J Nutr       Date:  2016-10-18       Impact factor: 5.614

3.  Plasma Leptin in Patients at Intermediate to High Cardiovascular Risk With and Without Type 2 Diabetes Mellitus.

Authors:  Martina Montagnana; Cristiano Fava; Giovanni Targher; Massimo Franchini; Elisa Danese; Sara Bonafini; Angela De Cata; Gian Luca Salvagno; Orazio Ruzzenente; Gian Cesare Guidi; Giuseppe Lippi
Journal:  J Clin Lab Anal       Date:  2016-07-29       Impact factor: 2.352

4.  Impact of hypoalphalipoproteinemia on quality of life in Taiwanese women with central obesity.

Authors:  I-Ju Chen; Wei-Chun Lin; Chia-Yu Liu; You-Lung Song; Jung-Peng Chiu; Chung-Hua Hsu
Journal:  Qual Life Res       Date:  2013-12-10       Impact factor: 4.147

5.  Significance of serum adiponectin levels in patients with chronic liver disease.

Authors:  Maria Luisa Balmer; Jeannine Joneli; Alain Schoepfer; Felix Stickel; Wolfgang Thormann; Jean-François Dufour
Journal:  Clin Sci (Lond)       Date:  2010-08-05       Impact factor: 6.124

6.  A comparison between body mass index and waist circumference for identifying continuous metabolic syndrome risk score components in Iranian school-aged children using a structural equation modeling approach: the CASPIAN-V study.

Authors:  Hanieh-Sadat Ejtahed; Zohreh Mahmoodi; Mostafa Qorbani; Pooneh Angoorani; Mohammad Esmaeil Motlagh; Shirin Hasani-Ranjbar; Hasan Ziaodini; Majzoubeh Taheri; Ramin Heshmat; Roya Kelishadi
Journal:  Eat Weight Disord       Date:  2020-08-09       Impact factor: 4.652

7.  Hypoadiponectinemia: A Link between Visceral Obesity and Metabolic Syndrome.

Authors:  Tiziana Di Chiara; Christiano Argano; Salvatore Corrao; Rosario Scaglione; Giuseppe Licata
Journal:  J Nutr Metab       Date:  2011-10-16

8.  Effects of Soy on Body Composition: A 12-Week Randomized Controlled Trial among Iranian Elderly Women with Metabolic Syndrome.

Authors:  A Bakhtiari; Z Yassin; P Hanachi; A Rahmat; Z Ahmad; P Sajadi; S Shojaei
Journal:  Iran J Public Health       Date:  2012-04-30       Impact factor: 1.429

9.  The effects of modified alternate-day fasting diet on weight loss and CAD risk factors in overweight and obese women.

Authors:  Samira Eshghinia; Fatemeh Mohammadzadeh
Journal:  J Diabetes Metab Disord       Date:  2013-01-09

10.  Risk interaction of obesity, insulin resistance and hormone-sensitive lipase promoter polymorphisms (LIPE-60 C > G) in the development of fatty liver.

Authors:  Pi-Jung Hsiao; Zhih-Cherg Chen; Wei-Wen Hung; Yi-Hsin Connie Yang; Mei-Yueh Lee; Jee-Fu Huang; Kung-Kai Kuo
Journal:  BMC Med Genet       Date:  2013-05-20       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.